Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ONCO Onconetix Inc.

交易中 10-01 13:24:53 EDT

0.7267

-0.0556

-7.11%

最高0.7800	最低0.7044	成交量65.09万
今开0.7800	昨收0.7823	日振幅9.66%
总市值286.98万	流通市值268.22万	总股本394.91万
成交额47.18万	换手率17.64%	流通股本369.09万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ONCO","market":"US","secType":"STK","nameCN":"Onconetix Inc.","latestPrice":0.7267,"timestamp":1790875395777,"preClose":0.7823,"halted":0,"volume":650898,"delay":0,"changeRate":-0.07107247858877666,"floatShares":3690899,"shares":3949107,"eps":-200.0809,"marketStatus":"交易中","change":-0.0556,"latestTime":"10-01 13:24:53 EDT","open":0.78,"high":0.78,"low":0.7044,"amount":471829.79619594,"amplitude":0.096638,"askPrice":0.7319,"askSize":807,"bidPrice":0.7226,"bidSize":101,"shortable":3,"etf":0,"ttmEps":-200.0809,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"listingDate":1645160400000,"exchange":"NASDAQ","adjPreClose":0.7823,"preHourTrading":{"tag":"盘前","latestPrice":0.7816,"preClose":0.7823,"latestTime":"09:08 EDT","volume":17027,"amount":13117.970285899999,"timestamp":1790860087403,"change":-0.0007,"changeRate":-0.000895,"amplitude":0.143935},"postHourTrading":{"tag":"盘后","latestPrice":0.7601,"preClose":0.7823,"latestTime":"19:59 EDT","volume":34868,"amount":26969.971493,"timestamp":1790812746735,"change":-0.0222,"changeRate":-0.028378,"amplitude":0.041416},"volumeRatio":0.065438},"requestUrl":"/m/hq/s/ONCO","defaultTab":"news","newsList":[{"id":"1105453260","title":"美股夜盘｜阿克迈续涨超20%，与Anthropic达成116亿美元的AI算力协议；ONCO大涨25%，获SRX Global增持少数股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1105453260","media":"美股夜盘","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105453260?lang=zh_cn&edition=full","pubTime":"2026-09-25 08:05","pubTimestamp":1790294754,"startTime":"0","endTime":"0","summary":"阿克迈涨20.49%，签署与Anthropic七年期116亿美元云服务协议，计划以其云基础设施支撑对CPU算力的需求。该合作包含扩展选项，潜在规模可进一步增加；公司向合作方授予认股权证，行权价111.33美元，并预计相关资本开支约55亿美元，其中17亿美元计入年度资本开支，管理层称不影响本年度营收指引。","market":"us","thumbnail":"https://static.tigerbbs.com/3fd9b4b7cbec67c68f3fbf44b021799e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3fd9b4b7cbec67c68f3fbf44b021799e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","AKAL","AKAM"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1165401360","title":"Onconetix并购标的Realbotix与欧洲电信巨头启动试点 将人形机器人引入现场演示与活动场景","url":"https://stock-news.laohu8.com/highlight/detail?id=1165401360","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165401360?lang=zh_cn&edition=full","pubTime":"2026-09-03 20:31","pubTimestamp":1788438676,"startTime":"0","endTime":"0","summary":"Onconetix Inc.的并购标的Realbotix，日前正式宣布启动一项全新试点项目。该项目携手一家欧洲领先的电信公司，旨在将人形机器人部署于现场演示与各类活动之中。这一合作标志着Realbotix在商业化应用领域的又一重要突破。对Realbotix而言，这是一次从实验室走向市场的关键实践。而对于Onconetix而言，这一进展也为其收购战略增添了新的看点。随着Realbotix不断拓展合作版图，其技术价值与市场潜力正逐步得到验证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167820801","title":"Onconetix 提交申请，股东拟转售最多1亿股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1167820801","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167820801?lang=zh_cn&edition=full","pubTime":"2026-08-13 04:10","pubTimestamp":1786565439,"startTime":"0","endTime":"0","summary":"路透社8月12日消息——Onconetix Inc.（纳斯达克代码：ONCO）近日对外披露，公司已向美国证券交易委员会（SEC）提交相关文件，计划允许特定股东对最多1亿股普通股进行转售。这一举措源自公司最新提交的证券注册声明，旨在为售股股东提供股份流通的通道。此次转售安排不涉及公司直接发行新股，而是由现有股东将其持有的股份在公开市场上进行处置。市场人士对此反应不一，但普遍关注该事件可能对股价带来的短期波动影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143402740","title":"Onconetix 提交申请，拟登记由售股股东转售最多1亿股普通股——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1143402740","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143402740?lang=zh_cn&edition=full","pubTime":"2026-08-13 01:55","pubTimestamp":1786557309,"startTime":"0","endTime":"0","summary":"Onconetix 已向美国证券交易委员会（SEC）提交文件，计划登记由特定售股股东转售高达1亿股普通股。此举旨在为股东提供流动性，并可能对市场供需格局产生一定影响。该申请文件标志着公司在资本运作方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125512736","title":"Onconetix收购目标Realbotix达成协议，人形机器人将亮相艾美奖获奖流媒体剧集","url":"https://stock-news.laohu8.com/highlight/detail?id=1125512736","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125512736?lang=zh_cn&edition=full","pubTime":"2026-08-06 20:31","pubTimestamp":1786019495,"startTime":"0","endTime":"0","summary":"Onconetix Inc.（ONCO）的收购目标——Realbotix，已正式敲定一项协议。根据协议内容，其人形机器人将获得一次宝贵机会，在艾美奖获奖流媒体剧集中登场亮相。这一合作标志着机器人技术在娱乐领域的又一重要突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170002441","title":"Onconetix 强调与 Realbotix 合作，携手 Bloom Services 在英国启动人形机器人试点项目以应对老年人社交孤立","url":"https://stock-news.laohu8.com/highlight/detail?id=1170002441","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170002441?lang=zh_cn&edition=full","pubTime":"2026-07-07 21:01","pubTimestamp":1783429278,"startTime":"0","endTime":"0","summary":"Onconetix 近日强调了其与 Realbotix 的合作关系，双方将联合 Bloom Services 在英国启动一项试点项目。该项目旨在利用人形机器人技术，应对日益严重的老年人社交孤立问题，探索科技在养老关怀领域的创新应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184060891","title":"Onconetix公司：招股说明书涉及Keystone Capital Partners将不时发售及出售公司最多2500万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1184060891","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184060891?lang=zh_cn&edition=full","pubTime":"2026-05-12 18:12","pubTimestamp":1778580772,"startTime":"0","endTime":"0","summary":"Onconetix Inc.发布公告称，一份招股说明书已提交备案，该文件涉及Keystone Capital Partners将不时发售及出售公司最多2500万股普通股。该销售行为将根据市场状况，通过多种方式进行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118630917","title":"Onconetix任命David White为首席执行官，Sammy Dorf为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1118630917","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118630917?lang=zh_cn&edition=full","pubTime":"2026-03-31 20:35","pubTimestamp":1774960528,"startTime":"0","endTime":"0","summary":"Onconetix Inc.宣布，公司已正式任命David White担任首席执行官一职。与此同时，Sammy Dorf被任命为公司董事会成员。此次人事变动旨在强化公司领导团队，推动公司未来发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518327463","title":"Onconetix, Inc.盘中异动 急速下跌10.39%报0.206美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518327463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518327463?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613561,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Onconetix, Inc.股票出现异动，股价快速下挫10.39%。截至发稿，该股报0.206美元/股，成交量24.7271万股，换手率1.70%，振幅8.13%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213241abf2fc8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213241abf2fc8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634706","title":"Onconetix, Inc.盘中异动 早盘股价大涨8.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516634706?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012392,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，Onconetix, Inc.股票出现波动，股价大幅拉升8.04%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.50%、28.40%、23.97%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Bioxcel Therapeutics, Inc.，振幅分别为21.22%、19.25%、10.83%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223313abe633de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223313abe633de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514032000","title":"Onconetix, Inc.盘中异动 早盘股价大跌5.57%报0.290美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514032000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514032000?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Onconetix, Inc.股票出现异动，股价快速下挫5.57%。截至发稿，该股报0.290美元/股，成交量4.7292万股，换手率0.33%，振幅1.30%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822313896341932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822313896341932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","VRPX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512314483","title":"Onconetix, Inc.盘中异动 早盘股价大跌5.60%报0.472美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512314483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512314483?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:38","pubTimestamp":1739975921,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时38分，Onconetix, Inc.股票出现波动，股价急速下挫5.60%。截至发稿，该股报0.472美元/股，成交量6.3897万股，换手率0.44%，振幅2.60%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223841988b32da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223841988b32da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510863052","title":"Onconetix, Inc.盘中异动 急速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510863052?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:39","pubTimestamp":1739198358,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时39分，Onconetix, Inc.股票出现波动，股价急速跳水5.26%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nls Pharmaceutics Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为1867.40%、1005.17%、682.93%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Invivyd, Inc.，振幅分别为42.01%、34.46%、29.90%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223918abc9a72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223918abc9a72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139","OCEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509744221","title":"Onconetix, Inc.盘中异动 早盘快速跳水6.46%报0.612美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509744221?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:47","pubTimestamp":1738939626,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时47分，Onconetix, Inc.股票出现波动，股价大幅下跌6.46%。截至发稿，该股报0.612美元/股，成交量5.1838万股，换手率0.36%，振幅5.83%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224706961b3bdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224706961b3bdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509094466","title":"Onconetix, Inc.盘中异动 快速拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509094466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509094466?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:15","pubTimestamp":1738685713,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时15分，Onconetix, Inc.股票出现异动，股价快速上涨5.09%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Evaxion Biotech As涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1628.65%、925.01%、444.73%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、49.88%、47.29%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001513abc23c81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001513abc23c81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508114921","title":"Onconetix, Inc.盘中异动 早盘快速跳水5.40%报0.515美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508114921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508114921?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:31","pubTimestamp":1738593065,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时31分，Onconetix, Inc.股票出现异动，股价大幅跳水5.40%。截至发稿，该股报0.515美元/股，成交量7.118万股，换手率0.49%，振幅0.00%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032231059616fb27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032231059616fb27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507631974","title":"Onconetix, Inc.盘中异动 快速下跌6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507631974?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:36","pubTimestamp":1738161388,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时36分，Onconetix, Inc.股票出现波动，股价快速下挫6.08%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012922362998760aac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012922362998760aac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506514639","title":"Onconetix, Inc.盘中异动 早盘股价大跌16.35%报0.538美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506514639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506514639?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074703,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Onconetix, Inc.股票出现异动，股价快速跳水16.35%。截至发稿，该股报0.538美元/股，成交量100.929万股，换手率12.17%，振幅83.68%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223143a2326ec8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223143a2326ec8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506667303","title":"Onconetix, Inc.盘中异动 股价大涨45.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506667303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506667303?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:31","pubTimestamp":1737988319,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时31分，Onconetix, Inc.股票出现波动，股价快速上涨45.23%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Akero Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、89Bio, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为719.52%、41.00%、35.87%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tevogen Bio Holdings Inc.、Akero Therapeutics, Inc.，振幅分别为13.94%、13.33%、11.19%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223200a2316acf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223200a2316acf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onconetix.com","stockEarnings":[{"period":"1week","weight":-0.1403},{"period":"1month","weight":0.2481},{"period":"3month","weight":-0.1813},{"period":"6month","weight":-0.9485},{"period":"1year","weight":-0.995},{"period":"ytd","weight":-0.99}],"compareEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":-0.0058},{"period":"3month","weight":0.024},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.1448},{"period":"ytd","weight":0.1184}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Onconetix, Inc.于2018年10月22日在特拉华州注册成立。该公司是一家商业阶段的生物技术公司，专注于为临床医生和患者提供肿瘤学专有疗法、诊断和服务的研究、开发和商业化。该公司目前拥有FDA批准的用于治疗良性前列腺增生（BPH）（一种前列腺疾病）的口服治疗药物EntadFi，以及用于在前列腺癌肿瘤学中筛查和诊断前列腺特异性抗原（PSA）评估不确定的男性的先进专有诊断系统Proclarix。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.03565},{"month":2,"riseRate":0,"avgChangeRate":-0.307056},{"month":3,"riseRate":0.2,"avgChangeRate":-0.25701},{"month":4,"riseRate":0,"avgChangeRate":-0.354557},{"month":5,"riseRate":0.6,"avgChangeRate":-0.00352},{"month":6,"riseRate":0.2,"avgChangeRate":-0.128372},{"month":7,"riseRate":0.2,"avgChangeRate":-0.004455},{"month":8,"riseRate":0,"avgChangeRate":-0.179053},{"month":9,"riseRate":0.4,"avgChangeRate":-0.110007},{"month":10,"riseRate":0.25,"avgChangeRate":-0.216685},{"month":11,"riseRate":0.25,"avgChangeRate":-0.325466},{"month":12,"riseRate":0,"avgChangeRate":-0.20858}],"exchange":"NASDAQ","name":"Onconetix Inc.","nameEN":"Onconetix Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Onconetix Inc.(ONCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Onconetix Inc.,ONCO,Onconetix Inc.股票,Onconetix Inc.股票老虎,Onconetix Inc.股票老虎国际,Onconetix Inc.行情,Onconetix Inc.股票行情,Onconetix Inc.股价,Onconetix Inc.股市,Onconetix Inc.股票价格,Onconetix Inc.股票交易,Onconetix Inc.股票购买,Onconetix Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Onconetix Inc.(ONCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}